Consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer: From concept to reality

Jose Serrano, Dana Andersen, Christopher E. Forsmark, Stephen J. Pandol, Ziding Feng, Sudhir Srivastava, Jo Ann S. Rinaudo

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Research progress in diseases of the exocrine pancreas [chronic pancreatitis (CP), pancreatogenic diabetes mellitus, and pancreatic cancer] has been hampered by the disorders' heterogeneity, the limitations of previous small cross-sectional studies, the inability to safely obtain pancreatic tissue for study, and the lack of structured epidemiology tools, genetic testing, and biomarker development. Mechanism-based research of these diseases has suffered from the lack of systematically collected clinical measures in longitudinal cohort studies linked with biospecimens. Given the increasing incidence and prevalence of CP and its association to the development of pancreatic cancer, its complications, high mortality rate, and associated health care cost, the National Institute for Diabetes and Digestive and Kidney Diseases and the National Cancer Institute funded the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer to identify research gaps and foster multidisciplinary collaborations to better diagnose, characterize, and manage CP and its sequelae. The CPDPC structure, governance, and research objectives are described in this article. Studies undertaken by the CPDPC are described in other articles in this journal's issue.

Original languageEnglish (US)
Pages (from-to)1208-1212
Number of pages5
JournalPancreas
Volume47
Issue number10
DOIs
StatePublished - Nov 1 2018
Externally publishedYes

Fingerprint

Chronic Pancreatitis
Pancreatic Neoplasms
Research
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.)
Exocrine Pancreas
National Cancer Institute (U.S.)
Genetic Testing
Health Care Costs
Longitudinal Studies
Diabetes Mellitus
Epidemiology
Cohort Studies
Cross-Sectional Studies
Biomarkers
Mortality
Incidence

Keywords

  • chronic pancreatitis
  • Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer
  • INSPPIRE
  • new-onset diabetes (NOD)
  • pancreatic cancer
  • PROCEED Study

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Endocrinology

Cite this

Serrano, J., Andersen, D., Forsmark, C. E., Pandol, S. J., Feng, Z., Srivastava, S., & Rinaudo, J. A. S. (2018). Consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer: From concept to reality. Pancreas, 47(10), 1208-1212. https://doi.org/10.1097/MPA.0000000000001167

Consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer : From concept to reality. / Serrano, Jose; Andersen, Dana; Forsmark, Christopher E.; Pandol, Stephen J.; Feng, Ziding; Srivastava, Sudhir; Rinaudo, Jo Ann S.

In: Pancreas, Vol. 47, No. 10, 01.11.2018, p. 1208-1212.

Research output: Contribution to journalArticle

Serrano, J, Andersen, D, Forsmark, CE, Pandol, SJ, Feng, Z, Srivastava, S & Rinaudo, JAS 2018, 'Consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer: From concept to reality', Pancreas, vol. 47, no. 10, pp. 1208-1212. https://doi.org/10.1097/MPA.0000000000001167
Serrano, Jose ; Andersen, Dana ; Forsmark, Christopher E. ; Pandol, Stephen J. ; Feng, Ziding ; Srivastava, Sudhir ; Rinaudo, Jo Ann S. / Consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer : From concept to reality. In: Pancreas. 2018 ; Vol. 47, No. 10. pp. 1208-1212.
@article{6e5f6b7c155e422fb647e8c4e2992fb4,
title = "Consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer: From concept to reality",
abstract = "Research progress in diseases of the exocrine pancreas [chronic pancreatitis (CP), pancreatogenic diabetes mellitus, and pancreatic cancer] has been hampered by the disorders' heterogeneity, the limitations of previous small cross-sectional studies, the inability to safely obtain pancreatic tissue for study, and the lack of structured epidemiology tools, genetic testing, and biomarker development. Mechanism-based research of these diseases has suffered from the lack of systematically collected clinical measures in longitudinal cohort studies linked with biospecimens. Given the increasing incidence and prevalence of CP and its association to the development of pancreatic cancer, its complications, high mortality rate, and associated health care cost, the National Institute for Diabetes and Digestive and Kidney Diseases and the National Cancer Institute funded the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer to identify research gaps and foster multidisciplinary collaborations to better diagnose, characterize, and manage CP and its sequelae. The CPDPC structure, governance, and research objectives are described in this article. Studies undertaken by the CPDPC are described in other articles in this journal's issue.",
keywords = "chronic pancreatitis, Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer, INSPPIRE, new-onset diabetes (NOD), pancreatic cancer, PROCEED Study",
author = "Jose Serrano and Dana Andersen and Forsmark, {Christopher E.} and Pandol, {Stephen J.} and Ziding Feng and Sudhir Srivastava and Rinaudo, {Jo Ann S.}",
year = "2018",
month = "11",
day = "1",
doi = "10.1097/MPA.0000000000001167",
language = "English (US)",
volume = "47",
pages = "1208--1212",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer

T2 - From concept to reality

AU - Serrano, Jose

AU - Andersen, Dana

AU - Forsmark, Christopher E.

AU - Pandol, Stephen J.

AU - Feng, Ziding

AU - Srivastava, Sudhir

AU - Rinaudo, Jo Ann S.

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Research progress in diseases of the exocrine pancreas [chronic pancreatitis (CP), pancreatogenic diabetes mellitus, and pancreatic cancer] has been hampered by the disorders' heterogeneity, the limitations of previous small cross-sectional studies, the inability to safely obtain pancreatic tissue for study, and the lack of structured epidemiology tools, genetic testing, and biomarker development. Mechanism-based research of these diseases has suffered from the lack of systematically collected clinical measures in longitudinal cohort studies linked with biospecimens. Given the increasing incidence and prevalence of CP and its association to the development of pancreatic cancer, its complications, high mortality rate, and associated health care cost, the National Institute for Diabetes and Digestive and Kidney Diseases and the National Cancer Institute funded the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer to identify research gaps and foster multidisciplinary collaborations to better diagnose, characterize, and manage CP and its sequelae. The CPDPC structure, governance, and research objectives are described in this article. Studies undertaken by the CPDPC are described in other articles in this journal's issue.

AB - Research progress in diseases of the exocrine pancreas [chronic pancreatitis (CP), pancreatogenic diabetes mellitus, and pancreatic cancer] has been hampered by the disorders' heterogeneity, the limitations of previous small cross-sectional studies, the inability to safely obtain pancreatic tissue for study, and the lack of structured epidemiology tools, genetic testing, and biomarker development. Mechanism-based research of these diseases has suffered from the lack of systematically collected clinical measures in longitudinal cohort studies linked with biospecimens. Given the increasing incidence and prevalence of CP and its association to the development of pancreatic cancer, its complications, high mortality rate, and associated health care cost, the National Institute for Diabetes and Digestive and Kidney Diseases and the National Cancer Institute funded the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer to identify research gaps and foster multidisciplinary collaborations to better diagnose, characterize, and manage CP and its sequelae. The CPDPC structure, governance, and research objectives are described in this article. Studies undertaken by the CPDPC are described in other articles in this journal's issue.

KW - chronic pancreatitis

KW - Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer

KW - INSPPIRE

KW - new-onset diabetes (NOD)

KW - pancreatic cancer

KW - PROCEED Study

UR - http://www.scopus.com/inward/record.url?scp=85055074677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055074677&partnerID=8YFLogxK

U2 - 10.1097/MPA.0000000000001167

DO - 10.1097/MPA.0000000000001167

M3 - Article

C2 - 30325859

AN - SCOPUS:85055074677

VL - 47

SP - 1208

EP - 1212

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 10

ER -